Morpho Sys AG
Martinsried, DE· latest recorded location
Morpho Sys AG is named on 7 US grants and 0 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 7
- Published applications
- 0
- Inventors
- 13
- Granted in 2026 so far
- 0
- Most recent grant
- 2 Aug 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 2 | 0 |
| 2016 | 3 | 0 |
By publication year.
Technology areas
Share of 7 documents
Recent patents
- Methods for identification of an antibody or a target2 Aug 2016US 9,404,929 B2
- Use of M-CSF antibodies in the treatment of osteoarthritis or pain26 Jan 2016US 9,243,066 B2
- Antibodies that are cross-reactive for macrophage migration inhibitory factor (MIF) and D-dopachrome tautomerase (D-DT)19 Jan 2016US 9,238,689 B2
- Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i1 Dec 2015US 9,200,061 B2
- Methods for the formation of disulphide bonds23 Jun 2015US 9,062,097 B2
No published applications.
Most cited
By later US patents